baking soda...cancer cure?

Byron

My apology:

"We have the NIH (National Institutes of Health of which the American Cancer Society is part) in America pointing out that a European court has ruled against this Italian doctor and they, with all their resources and money (NIH and ACS) not even doing a scientific study to prove the doctor correct or mistaken."

The American Cancer Society is not part of NIH.  It is the National Cancer Institute that is part of NIH:

http://www.nih.gov/icd/

LJ13 is correct: "...The American Cancer Society is a private charity. They do provide some funding for research, but are largely dedicated to advocacy and education...."

LJ13, exact who is it that they advocate for?  Do they provide finding for NIH (and the National Cancer Institute)?  In other words are they a Washington lobby (for some special interest group(s), like doctors and other health care professionals) and the drug industry? Answer please.  From where I come from, we often refer to "education" as brainwashing.

Byron

Husband11

Its hard to believe that the good Doctor Simoncini is so compelled by the evidence he's found as to the cause and cure of cancer, that he could not share such compelling evidence with his colleagues.   Its also difficult to understand that a man that wants to help people, wouldn't take the time to ensure that his "cure" reaches mainstream acceptance and help the whole world, not just the people he has time to treat.  There may be explanations why this is, but I can't think of any good one.  Can you imagine the Doctor that discovered insulin or penicillin, saying, "Oh, screw it, I'm not going to take the time to present my work to my colleagues and have this understood and accepted, I'll just languish in ridicule and keep it to myself, treat a handful of patients in hidden locations, away from the hands of authority."

crazy4carrots

Byron, the ACS raises funds for research, education, comunity support and awareness.  I believe at leat 50% of its annual fundraising goes directly to the National Cancer Institute.  No doubt the ACS also does some lobbying in an effort to have more federal funds directed towards cancer research.  I can't see that as a bad thing.....

I've been reading these posts over the last few days and am wondering why you seem so determined to defend this Italian doctor?  There are so many, many nasty individuals who claim to have the "cure", and whose claims are denounced by people of integrity.  When Simoncelli's own government denounces him amd charges him with fraud, and takes away his licence to practice medicine, that would seem to be the clearest evidence to stay away from him.

Of course, if, as you say, where you come from, education is referred to as brainwashing, then I guess there really is nothing any of us can say to dissuade you.

Anonymous

ADVOCACY & PUBLIC POLICY

Cancer is a political issue. Every day, government policymakers make decisions that affect the lives of nearly 10 million cancer patients, survivors, their families, and all those at risk for developing cancer. To impact those decisions positively, the Society has identified advocacy as one of its top corporate priorities and works nationwide to promote beneficial policies, laws, and regulations for those affected by cancer.

Issues and Answers
In concert with its cancer research, prevention, and control initiatives, the Society's advocacy initiatives strive to influence public policies with special emphasis on laws or regulations to:

* Finance cancer research initiatives
* Ensure access to quality health care
* Reform managed care and protect patients
* Allow scientists to conduct potentially beneficial genetic and bioresearch with appropriate review and controls in place
* Prevent and reduce tobacco use
* Increase access to and participation in clinical trials
* Improve the management of cancer pain and symptoms
* Reduce cancer incidence rates and deaths among the medically underserved
* Provide early detection and treatment options for site-specific cancers

http://www.cancer.org/docroot/AA/content/AA_2_3_Advocacy_and_Public_Policy.asp?sitearea=AA

They do not provide funding to any government agency. Any research funding they provide is directly to the researchers, e.g. university research labs. A lobby? Yes, I guess you could consider part of what they do as a lobby. They do not lobby for drug companies, but as described above, for public policy directed at eliminating cancer.

Lobby is not always a bad word. There are thousands of conflicting voices pommeling the ears of legislators and regulators. It's the system. Even good groups must have a voice to be heard.

Byron

lindasa and LJ13,

lindasa wrote:

"...Byron, the ACS raises funds for research, education, comunity support and awareness.  I believe at leat 50% of its annual fundraising goes directly to the National Cancer Institute.  No doubt the ACS also does some lobbying in an effort to have more federal funds directed towards cancer research.  I can't see that as a bad thing...."

LJ13 wrote:

"They [American Cancer Society] do not provide funding to any government agency.

Which of you are we to believe?

Byron

crazy4carrots

Well, Byron, I live in Canada and I assumed that the ACS operates in much the same way as the Canadian Cancer Society, which directs 51% of its fundraising dollars to the National Cancer Institute of Canada.  The NCIC is responsible for distributing peer-reviewed research grants to deserving scientists whose work holds promise.  Perhaps LJ13 can clear this up for us as per the ACS and its relationship (if any) to the NCI.

Regardless, are you saying that the ACS should not be providing research dollars to the NCI, and if so, why?

FloridaLady

Government agency and a good thing? Please who really believe this? Show me when this is ever a good thing?  American Cancer Society I want proof of where their Billions go each year?  They collect billions for the last fifty years.  Never meet a research clinic that had any money from them or a person who they have helped. (I've easly have meet or spoken to well over one hundred patients.)  And I don't mean a free wigs that were given to them for free by another patient.  Or lovely volunteers who give THEIR TIME FOR FREE.   Not a employee of of ACS!  Sixty five percent of research is paid by the pharm. companies..goverment grants.  Where the hell is Susan B Komen and ACS billions going?

I can pull up law suits for every chemo and procedure you can get in America for cancer.  If doctor's were sued in the US every time someone died we have know doctor's to got too. I'll tell my family to sue MD Anderson for me they deserve it.  But wait.. they make you sign your life away when you walk in the door. You no longer have any rights! You sign away the rights to sue!

Flalady

crazy4carrots

That's a pretty inflammatory condemnation of the American Cancer Society, and I cannot believe it is deserved.  Perhaps a bit more "research" needs to be done re the granting procedures of the ACS, who is receiving the grants, and the research they're doing, rather than saying that you have never personally encountered anyone who has been helped by ACS-supported research.  Tell me, how many cancer patients would actually know that?

Are you also suggesting that the U.S. government should NOT support cancer research?  Sounds like it to me.......

wendy57

If you want to know where Susan G. Komen Foundation's money goes - it is very easy to access their annual reports, final audited financial statements and even copies of their tax returns on their website:   http://ww5.komen.org/

FloridaLady

Please show me some one who received real value you from ACS.  They rec'd 50 billion last year.  To buy wigs & prosthetics? (most are donoted)  patient transportation for the most part is by volunteers in the own car's with their own money? Yes they will pay for a taxes ride sometime at what cost? Pay their CFO $620,000 a year? They spend .13 cent of every dollar on cancer. The rest is overhead. As noted I have talk to well over one hundred patients in the last three and half years in three different clinics and in multiple states.  Yes, I have spoken to a few!  I'm also receiving my treatment at a very good clinic that is in a low income area.  I've had opportunity to talk to people who need help.  Many of these are older patients. Everyone I spoke to only rec'd help with transportation PERIOD! There are other originzations I've never heard of also helping many people very quitely without the HUGH over head. I've meet people who were uninsured who need help finding how to get drugs...believe it or not...it came from the pharm companies. Not just chemo but the meds for side effects.  ACS and Komen job is supposedly to help others with early detection for low income people. Then they drop you like a hot potato.  They do not help you find a place for treatment as a uninsued person when needed or work with the drug companies to get needed drugs.  Meet a lady after going these routes her breast surgeon said she may have to call her local senator to get some help. YES I would like to know were all the ACS & Komen money is going! How many mammo can you do for a couple of billion dollars a year!  I've yet to see were the research dollars go.  The only research I've seen was...How does bc effect you on the job.  Let's see I'm stage iv and you really think I care about the trial info being collected? How many millions would you like to spend to find this out?

I'm saying ACS, Komen and the government should be put under a magnify glass we have the right to know where this money is coming from and where it is going. These all have become BIG business. That is when corruptions starts!

Flalady

crazy4carrots

I personally know cancer researchers here in Canada who receive NCI funding for their research -- oh, by the way, basic research, the kind done in laboratories, the kind that will help lead to a cure for this disease.  They work in collaboration with U.S. scientists whose work is funded by NCI and the ACS.  One of the discoverers of the BCRA 1 and 2 genes (Dr. Steven Narod) is in Toronto, and he has received grants from the U.S. army for some of his work!  But I guess you wouldn't want your tax dollars -- via the U.S. army -- to aid in finding a cure, or at least prevention.......

Byron

Timothy wrote:

"Its hard to believe that the good Doctor Simoncini is so compelled by the evidence he's found as to the cause and cure of cancer, that he could not share such compelling evidence with his colleagues.   Its also difficult to understand that a man that wants to help people, wouldn't take the time to ensure that his 'cure' reaches mainstream acceptance and help the whole world, not just the people he has time to treat.  There may be explanations why this is, but I can't think of any good one.  Can you imagine the Doctor that discovered insulin or penicillin, saying, 'Oh, screw it, I'm not going to take the time to present my work to my colleagues and have this understood and accepted, I'll just languish in ridicule and keep it to myself, treat a handful of patients in hidden locations, away from the hands of authority.' "

Where, Tomothy, did you find this information?

LJ13 wrote:

...[the American Cancer Society] "advocacy initiatives strive to influence public policies with special emphasis on laws or regulations to"...

" * Finance cancer research initiatives [to benefit their members]
" * Ensure access to quality health care [to benefit their members]
" * Reform managed care and protect patients [to benefit their members]
" * Allow scientists to conduct potentially beneficial genetic and bioresearch with appropriate review and controls in place [to benefit their members]
" * Prevent and reduce tobacco use [especially when it benefits their members]
" * Increase access to and participation in clinical trials [to benefit their members]
" * Improve the management of cancer pain and symptoms [to benefit their members]
" * Reduce cancer incidence rates and deaths among the medically underserved [when doing so benefits their members]
" * Provide early detection and treatment options for site-specific cancers [to benefit their members]"

And by the way, LJ13, you have not yet answered my last post.

Byron

Hindsfeet

What does it matter? I've tried medicine that doesn't work. Doctors will precribe medicine, and later decide it's the wrong med's for you. Doctor Simoncini baking soda shouldn't kill anyone. If my cancer was invasive I would try it as one of many options. The baking soda killed my friends mushrooms in a few days...I saw it.

A lot of acceptable medicine in the beginning has bad reviews. It took awhile for penacillin to be accepted. Doctor Simoncini is sharing openly on the u-tube...and anyone hearing it can try it or asked him for the recepie. He isn't keeping secrets. And I like the man's spirit. He is offering a inexpensive approach for cancer. It may not cure, but it might help.

 Lets not speak to soon. I heard of someone whom was cured by him. None of us has a corner on the market when it comes to cancer cures or treatment.  B. Barry

motheroffoursons

Barry, from your post,

"Doctor Simoncini baking soda shouldn't kill anyone. If my cancer was invasive I would try it as one of many options. The baking soda killed my friends mushrooms in a few days...I saw it."

1.  It did kill people and we presented the evidence.

2.  I pray that you and your family do not ever have to deal with invasive cancer.

3.  Killing mushrooms does not establish anything.  I can dump bleach or hydrochloric acid on mushrooms and kill them.  That does not make it a viable alternative medicine for cancer and for injection into the body.

Science is a process, and yes sometimes they are wrong.  However, there is no science in this baking soda cure, only quacks trying to cash in on the hopes of other people.

Alternative methods are great, but the field of alternative medicine also has some quacks.  This is one of them.

Anonymous

Byron, actually I have a life and don't spend all my time on this forum.

I honestly don't care whom you believe. My information came from the ACS web site and their annual report. It does not break down distributions for research, but makes no mention of providing funds to NCI. That isn't how things work here in the US. There has to be a clear delineation between public funds and private funds. Any intermixture and the charity is at risk of losing tax exempt status. So I do not believe ACS provides any money to NCI.

As usual, Fla"Lady"s statistics are off exponentially. ACS balance sheet lists 2007 income as 916 million, not $50 billion.Charity Navigator lists their expenses as follows: Program Expenses 68.4%; Administrative Expenses 9.6%; Fundraising Expenses 21.8%. Program Expenses would represent money spent on their missions, including advocacy and education (their primary missions) as well as research grants. Overhead would be represented in Admin Expenses and Fundraising Expenses, which are about 30% combined, not the 87% Fla"Lady" suggests.

Anonymous

Some of the ways I benefitted from ACS programs during my diagnosis and treatment included many brochures that provided information that was useful to me. There were dozens of such brochures at my hospital. The nutrition guide was particularly useful, with lots of diet and meal suggestions for people on chemo.

In addition, there is a Patient Navigator at my hospital who was there do help in any way she could. Information, understanding hospital processes, providing a pad and paper for making notes, whatever she could do to help, she did. She is an ACS employee.

Their web site is loaded with information on cancer and treatments. It costs a lot of money to keep such a large web site running.

I don't expect ACS to fund the cure ... what they do, their services are useful and important to many people. I expect university professors to discover new theories, and I expect private companies to turn those theories into diagnostic tools and treatments. That's how it's been working for decades, and we have made tremendous progress. There is still a far way to go.

Byron

LJ13,

We are all happy you survived; and thanks for the research in your post.

If you, like so many others, had died, you would not be here to complain about the lack of scientific research from ACS and NIH.  It just seems to me that someone (an independent source), would do us all a favor by scientifically investigating the claims of benefits by using Baking soda.  Unfortunately, ACS is not independent (as shown from statements in their website).  Until an independent someone (research group and/or government source(s)...) looks at the claims of  this Italian with a reliable study, none of us will ever know if it is or is not a useful treatment.

Byron

crazy4carrots

Byron, the very fact that NO studies have been done, or at least published, by any reputable scientists worldwide, should tell you that they feel there is no scientific basis for pursuing research in this area.

Scientific research is extremely expensive; dollars/pounds/euros/yens etc. should not be wasted on the basis of one discredited doctor who claims he has a cure for cancer, IMHO.

Byron

lindasa wrote:

"Byron, the very fact that NO studies have been done, or at least published, by any reputable scientists worldwide, should tell you that they feel there is no scientific basis for pursuing research in this area.

"Scientific research is extremely expensive; dollars/pounds/euros/yens etc. should not be wasted on the basis of one discredited doctor who claims he has a cure for cancer, IMHO."

Do you realize, lindasa, just how insane your statement is?  That is exactly the kind of study/studies where research dollars should be invested.

Byron

orange1

Byron-

When we were kids, my older sister and I would mix up stuff we found in the medicine cabinet and try to get my younger brother to take the 'medicine'.  We put all sorts of stuff in it.  Looking back, it was probably a lot of antacid or milk of mag, toothpaste and foot powder, who knows what, I was maybe 5 or 6 at the time. 

The point is that antacid, toothpaste and foot powder seems like as good a choice as baking soda and maple syrup since there is no scientific for either of them.  Would you like precious research $$ to go toward antacid toothpaste and baking soda?

FloridaLady

Do the research ACS spends less than 13 to 20% on research (you can only see info online up to 2000, than no more years posted?????)   and Susan B Komen only spends 25% on research! (you can see their budget online) There is no publicly posted "current info" on ACS financial reports or budget? People are blindly giving and not questions this orgianization for years.    American funds this and the financial and budget should be made PUBLIC!  And it's in the billions no millions.

I find it very interesting no one is willing to push this "charity???" to expose it's activities.

American Cancer Society:   The World's Wealthiest "Nonprofit" .

• Conflicts of Interest
  - Mammography Industry
  - Pesticide Industry
  - Drug Industry
• Board of Trustees

The American Cancer Society is fixated on damage control- diagnosis and treatment- and basic molecular biology, with indifference or even hostility to cancer prevention. This myopic mindset is compounded by interlocking conflicts of interest with the cancer drug, mammography, and other industries. The "nonprofit" status of the Society is in sharp conflict with its high overhead and expenses, excessive reserves of assets and contributions to political parties. All attempts to reform the Society over the past two decades have failed; a national economic boycott of the Society is long overdue.

The American Cancer Society (ACS) is accumulating great wealth in its role as a "charity." According to James Bennett, professor of economics at George Mason University and recognized authority on charitable organizations, in 1988 the ACS held a fund balance of over $400 million with about $69 million of holdings in land, buildings, and equipment (1). Of that money, the ACS spent only $90 million- 26 percent of its budget- on medical research and programs. The rest covered "operating expenses," including about 60 percent for generous salaries, pensions, executive benefits, and overhead. By 1989, the cash reserves of the ACS were worth more than $700 million (2). In 1991, Americans, believing they were contributing to fighting cancer, gave nearly $350 million to the ACS, 6 percent more than the previous year. Most of this money comes from public donations averaging $3,500, and high-profile fund-raising campaigns such
as the springtime daffodil sale and the May relay races. However, over the last two decades, an increasing proportion of the ACS budget comes from large corporations, including the pharmaceutical, cancer drug, telecommunications, and entertainment industries.

In 1992, the American Cancer Society Foundation was created to allow the ACS to actively solicit contributions of more than $100,000. However, a close look at the heavy-hitters on the Foundation's board will give an idea of which interests are at play and where the Foundation expects its big contributions to come from. The Foundation's board of trustees included corporate executives from the pharmaceutical, investment, banking, and media industries. Among them:

• David R. Bethune, president of Lederle Laboratories, a multinational pharmaceutical company and a division of American Cyanamid Company. Bethune is also vice president of American Cyanamid, which makes chemical fertilizers and herbicides while transforming itself into a full-fledged pharmaceutical company. In 1988, American Cyanamid introduced Novatrone, an anti-cancer drug. And in 1992, it announced that it would buy a majority of shares of Immunex, a cancer drug maker.
  
  
• Multimillionaire Irwin Beck, whose father, William Henry Beck, founded the nation's largest family-owned retail chain, Beck Stores, which analysts estimate brought in revenues of $1.7 billion in 1993.
  
  
• Gordon Binder, CEO of Amgen, the world's foremost biotechnology company, with over $1 billion in product sales in 1992. Amgen's success rests almost exclusively on one product, Neupogen, which is administered to chemotherapy patients to stimulate their production of white blood cells. As the cancer epidemic grows, sales for Neupogen continue to skyrocket.
  
  
• Diane Disney Miller, daughter of the conservative multi-millionaire Walt Disney, who died of lung cancer in 1966, and wife of Ron Miller, former president of the Walt Disney Company from 1980 to 1984.
  
• George Dessert, famous in media circles for his former role as censor on the subject of "family values" during the 1970s and 1980s as CEO of CBS, and now chairman of the ACS board.
  
  
• Alan Gevertzen, chairman of the board of Boeing, the world's number one commercial aircraft maker with net sales of $30 billion in 1992.
  
  
• Sumner M. Redstone, chairman of the board, Viacom Inc. and Viacom International Inc., a broadcasting, telecommunications, entertainment, and cable television corporation.

The results of this board's efforts have been very successful. A million here, a million there- much of it coming from the very industries instrumental in shaping ACS policy, or profiting from it. In 1992, The Chronicle of Philanthropy reported that the ACS was "more interested in accumulating wealth than in saving lives." Fund-raising appeals
routinely stated that the ACS needed more funds to support its cancer programs, all the while holding more than $750 million in cash and real estate assets (3). A 1992 article in the Wall Street Journal, by Thomas DiLorenzo, professor of economics at Loyola College and veteran investigator of nonprofit organizations, revealed that the Texas affiliate of the ACS owned more than $11 million worth of assets in land and real estate, as well as more than 56 vehicles, including
11 Ford Crown Victorias for senior executives and 45 other cars assigned to staff members. Arizona's ACS chapter spent less than 10 percent of its funds on direct community cancer services. In California, the figure was 11 percent, and under 9 percent in Missouri (4):

Thus for every $1 spent on direct service, approximately $6.40 is spent on compensation and overhead. In all ten states, salaries and fringe benefits are by far the largest single budget items, a surprising fact in light of the characterization of the appeals, which stress an urgent and critical need for donations to provide cancer services.

Nationally, only 16 percent or less of all money raised is spent on direct services to cancer victims, like driving cancer patients from the hospital after chemotherapy and providing pain medication.

Most of the funds raised by the ACS go to pay overhead, salaries, fringe benefits, and travel expenses of its national executives in Atlanta. They also go to pay chief executive officers, who earn six-figure salaries in several states, and the hundreds of other employees who work out of some 3,000 regional offices nationwide. The typical ACS affiliate, which helps raise the money for the national office, spends more than 52 percent of its budget on salaries, pensions, fringe benefits, and overhead for its own employees. Salaries and overhead for most ACS affiliates also exceeded 50 percent, although most direct community services are handled by unpaid volunteers. DiLorenzo summed up his findings by emphasizing the hoarding of funds by the ACS (4):

If current needs are not being met because of insufficient funds, as fund-raising appeals suggest, why is so much cash being hoarded? Most contributors believe their donations are being used to fight cancer, not to accumulate financial reserves. More progress in the war against cancer would be made if they would divest some of their real estate holdings and use the proceeds- as well as a portion of their cash reserves- to provide more cancer services.

Aside from high salaries and overhead, most of what is left of the ACS budget goes to basic research and research into profitable patented cancer drugs. The current budget of the ACS is $380 million and its cash reserves approach $1 billion. Yet its aggressive fund-raising campaign continues to plead poverty and lament the lack of available money for cancer research, while ignoring efforts to prevent cancer by phasing out avoidable exposures to environmental and occupational carcinogens. Meanwhile, the ACS is silent about its intricate
relationships with the wealthy cancer drug, chemical, and other industries. A March 30, 1998, Associated Press Release shed unexpected light on questionable ACS expenditures on lobbying (5). National vice president for federal and state governmental relations Linda Hay Crawford admitted that the ACS was spending "less than $1 million a year on direct lobbying." She also admitted that over the last year, the society used ten of its own employees to lobby. "For legal
and other help, it hired the lobbying firm of Hogan & Hartson, whose roster includes former House Minority Leader Robert H. Michel (R- IL)." The ACS lobbying also included $30,000 donations to Democratic and Republican governors' associations. "We wanted to look like players and be players," explained Crawford. This practice, however, has been sharply challenged. The Associated Press release quotes the national Charities Information Bureau as stating that it" does not know of any other charity that makes contributions to political parties."
Tax experts have warned that these contributions may be illegal, as charities are not allowed to make political donations. Marcus Owens, director of the IRS Exempt Organization Division, also warned that "The bottom line is campaign contributions will jeopardize a charity's exempt status."

TRACK RECORD ON PREVENTION
Marching in lockstep with the National Cancer Institute (NCI) in its "war" on cancer is its "ministry of information," the ACS (6, pp. 306- 314). With powerful media control and public relations resources, the ACS is the tail that wags the dog of the policies and priorities of the NCI (7, 8). In addition, the approach of the ACS to cancer prevention reflects a virtually exclusive "blame-the-victim" philosophy. It emphasizes faulty lifestyles rather than unknowing and avoidable
exposure to workplace or environmental carcinogens. Giant corporations, which profit handsomely while they pollute the air, water, and food with a wide range of carcinogens, are greatly comforted by the silence of the ACS. This silence reflects a complex of mindsets fixated on diagnosis, treatment, and basic genetic research together with ignorance, indifference, and even hostility to prevention, coupled with conflicts of interest.

Indeed, despite promises to the public to do everything to "wipe out cancer in your lifetime," the ACS fails to make its voice heard in Congress and the regulatory arena. Instead, the ACS repeatedly rejects or ignores opportunities and requests from Congressional committees, regulatory agencies, unions, and environmental organizations to provide scientific testimony critical to efforts
to legislate and regulate a wide range of occupational and environmental carcinogens. This history of ACS unresponsiveness is a long and damning one, as shown by the following examples (6):

1. In 1971, when studies unequivocally proved that diethylstilbestrol (DES) caused vaginal cancers in teenaged daughters of women administered the drug during pregnancy, the ACS refused an invitation to testify at Congressional hearings to require the FDA (U. S. Food and Drug Administration) to ban its use as an animal feed additive. It gave no reason for its refusal.

2. In 1977 and 1978, the ACS opposed regulations proposed for hair coloring products that contained dyes known to cause breast and liver cancer in rodents. In so doing, the ACS ignored virtually every tenet of responsible public health as these chemicals were clear-cut liver and breast carcinogens.

3. In 1977, the ACS called for a Congressional moratorium on the FDA's proposed ban on saccharin and even advocated its use by nursing mothers and babies in "moderation" despite clear-cut evidence of its carcinogenicity in rodents. This reflects the consistent rejection by the ACS of the importance of animal evidence as predictive of human cancer risk.

4. In 1978, Tony Mazzocchi, then senior representative of the Oil, Chemical, and Atomic Workers International Union, stated at a Washington, D. C., round-table between public interest groups and high-ranking ACS officials: "Occupational safety standards have received no support from the ACS."

5. In 1978, Congressman Paul Rogers censured the ACS for doing "too little, too late" in failing to support the Clean Air Act.

6. In 1982, the ACS adopted a highly restrictive cancer policy that insisted on unequivocal human evidence of carcinogenicity before taking any position on public health hazards. Accordingly, the ACS still trivializes or rejects evidence of carcinogenicity in experimental animals, and has actively campaigned against laws (the 1958 Delaney Law, for instance) that ban deliberate addition to food of
any amount of any additive shown to cause cancer in either animals or humans. The ACS still persists in an anti-Delaney policy, in spite of the overwhelming support for the Delaney Law by the independent scientific community.

7. In 1983, the ACS refused to join a coalition of the March of Dimes, American Heart Association, and the American Lung Association to support the Clean Air Act.

8. In 1992, the ACS issued a joint statement with the Chlorine Institute in support of the continued global use of organochlorine pesticides- despite clear evidence that some were known to cause breast cancer. In this statement, Society vice president Clark Heath, M. D., dismissed evidence of this risk as "preliminary and mostly based on weak and indirect association." Heath then went on to explain away the blame for increasing breast cancer rates as due to better detection: " Speculation that such exposures account for observed geographic differences in breast cancer incidence or for recent rises in breast cancer occurrence should be received with caution; more likely, much of the recent rise in incidence in the United States . . . reflects increased utilization of mammography over the past decade."

9. In 1992, in conjunction with the NCI, the ACS aggressively launched a " chemoprevention" program aimed at recruiting 16,000 healthy women at supposedly " high risk" of breast cancer into a 5-year clinical trial with a highly profitable drug called tamoxifen. This drug is manufactured by one of the world's most powerful cancer drug industries, Zeneca, an offshoot of the Imperial Chemical Industries. The women were told that the drug was essentially harmless, and that it could reduce their risk of breast cancer. What the women were not told was that tamoxifen had already been shown to be a highly potent liver carcinogen in rodent tests, and also that it was well-known to induce human uterine cancer (6, pp. 145- 151).

10. In 1993, just before PBS Frontline aired the special entitled "In Our
Children's Food," the ACS came out in support of the pesticide industry. In a damage-control memorandum sent to some 48 regional divisions, the ACS trivialized pesticides as a cause of childhood cancer, and reassured the public that carcinogenic pesticide residues in food are safe, even for babies. When the media and concerned citizens called local ACS chapters, they received reassurances
from an ACS memorandum by its vice president for Public Relations (9): "

The primary health hazards of pesticides are from direct contact with the chemicals at potentially high doses, for example, farm workers who apply the chemicals and work in the fields after the pesticides have been applied, and people living near aerially sprayed fields. . . . The American Cancer Society believes that the benefits of a balanced diet rich in fruits and vegetables far outweigh the largely theoretical risks posed by occasional, very low pesticide
residue levels in foods."

11. In September 1996, the ACS together with a diverse group of patient and physician organizations filed a "citizen's petition" to pressure the FDA to ease restrictions on access to silicone gel breast implants. What the ACS did not disclose was that the gel in these implants had clearly been shown to induce cancer in several industry rodent studies, and that these implants were also contaminated
with other potent carcinogens such as ethylene oxide and crystalline silica. This abysmal track record on prevention has been the subject of periodic protests by both independent scientists and public interest groups. A well-publicized example was a New York City, January 23, 1994, press conference, sponsored by the author and the Center for Science in the Public Interest. The press release stated: "A group of 24 scientists charged that the ACS was doing little to protect the public from cancer-causing chemicals in the environment and workplace. The scientists urged ACS to revamp its policies and to emphasize prevention in its lobbying and educational campaigns." The
scientists- who included Matthew Meselson and Nobel laureate George Wald, both of Harvard University; former OSHA director Eula Bingham; Samuel Epstein, author of The Politics of Cancer; and Anthony Robbins, past president of the American Public Health Association- criticized the ACS for insisting on unequivocal human proof that a substance is carcinogenic before it will recommend its regulation.

This public criticism by a broad representation of highly credible scientists reflects the growing conviction that a substantial proportion of cancer deaths are caused by exposure to chemical carcinogens in the air, water, food supply, and workplace, and thus can be prevented by legislative and regulatory action. Calling the ACS guidelines an "unrealistically high-action threshold," a letter to ACS executive vice president Lane Adams states that "we would like to express
our hope that ACS will take strong public positions and become a more active force to protect the public and the work force from exposure to carcinogens." ACS's policy is retrogressive and contrary to authoritative and scientific tenets established by international and national scientific committees, and is in conflict with long-established policies of federal regulatory agencies. Speakers at the conference warned that unless the ACS became more supportive of cancer prevention, it would face the risk of an economic boycott. Reacting promptly, the ACS issued a statement claiming that cancer prevention would become a major priority. However, ACS policies have remained unchanged. More recently, the author has issued this warning again, a warning echoed by activist women's breast cancer groups.

In Cancer Facts & Figures- 1998, the latest annual ACS publication designed to provide the public and medical profession with "Basic Facts" on cancer- other than information on incidence, mortality, signs and symptoms, and treatment- there is little or no mention of prevention (10). Examples include: no mention of dusting the genital area with talc as a known cause of ovarian cancer; no mention of parental exposure to occupational carcinogens as a major cause of
childhood cancer; and no mention of prolonged use of oral contraceptives and hormone replacement therapy as major causes of breast cancer. For breast cancer, ACS states: "Since women may not be able to alter their personal risk factors, the best opportunity for reducing morality is through early detection." In other words, breast cancer is not preventable in spite of clear evidence that its incidence
has escalated over recent decades, and in spite of an overwhelming literature on avoidable causes of this cancer (6, Chapt. 6). In the section on "Nutrition and Diet," no mention at all is made of the heavy contamination of animal and dairy fats and produce with a wide range of carcinogenic pesticide residues, and on the need to switch to safer organic foods.

CONFLICTS OF INTEREST
Of the members of the ACS board, about half are clinicians, oncologists, surgeons, radiologists, and basic molecular scientists- and most are closely tied in with the NCI. Many board members and their institutional colleagues apply for and obtain funding from both the ACS and the NCI. Substantial NCI funds go to ACS directors who sit on key NCI committees. Although the ACS asks board members to leave the room when the rest of the board discusses their funding
proposals, this is just a token formality. In this private club, easy access to funding is one of the "perks," and the board routinely rubber-stamps approvals. A significant amount of ACS research funding goes to this extended membership. Such conflicts of interest are evident in many ACS priorities, including their policy on mammography and their National Breast Cancer Awareness campaign (6).

Mammography
The ACS has close connections to the mammography industry. Five radiologists have served as ACS presidents, and in its every move, the ACS reflects the interests of the major manufacturers of mammogram machines and films, including Siemens, DuPont, General Electric, Eastman Kodak, and Piker. In fact, if every woman were to follow ACS and NCI mammography guidelines, the annual revenue to health care facilities would be a staggering $5 billion, including at least $2.5 billion for premenopausal women. Promotions of the ACS continue to
lure women of all ages into mammography centers, leading them to believe that mammography is their best hope against breast cancer. A leading Massachusetts newspaper featured a photograph of two women in their twenties in an ACS advertisement that promised early detection results in a cure "nearly 100 percent of the time." An ACS communications director, questioned by journalist Kate Dempsey, responded in an article published by the Massachusetts Women's
Community's journal Cancer: "The ad isn't based on a study. When you make an advertisement, you just say what you can to get women in the door. You exaggerate a point. . . . Mammography today is a lucrative [and] highly competitive business."

In addition, the mammography industry conducts research for the ACS and its grantees, serves on advisory boards, and donates considerable funds. DuPont also is a substantial backer of the ACS Breast Health Awareness Program; sponsors television shows and other media productions touting mammography; produces advertising, promotional, and information literature for hospitals, clinics, medical organizations, and doctors; produces educational films; and, of course, lobbies Congress for legislation promoting availability of mammography services. In virtually all of its important actions, the ACS has been strongly linked with the mammography industry, ignoring the development of viable alternatives to mammography.

The ACS exposes premenopausal women to radiation hazards from mammography with little or no evidence of benefits. The ACS also fails to tell them that their breasts will change so much over time that the "baseline" images have little or no future relevance. This is truly an American Cancer Society crusade. But against whom, or rather, for whom?

National Breast Cancer Awareness Month
The highly publicized National Breast Cancer Awareness Month campaign further illustrates these institutionalized conflicts of interest. Every October, ACS and NCI representatives help sponsor promotional events, hold interviews, and stress the need for mammography. The flagship of this month-long series of
events is National Mammography Day, on October 17 in 1997.
Conspicuously absent from the public relations campaign of the National Breast Cancer Awareness Month is any information on environmental and other avoidable causes of breast cancer. This is no accident. Zeneca Pharmaceuticals- a spin-off of Imperial Chemical Industries, one of the world's largest manufacturers of chlorinated and other industrial chemicals, including those incriminated as causes of breast cancer- has been the sole multimillion-dollar funder of
National Breast Cancer Awareness Month since its inception in 1984. Zeneca is also the sole manufacturer of tamoxifen, the world's top-selling anticancer and breast cancer "prevention" drug, with $400 million in annual sales. Furthermore, Zeneca recently assumed direct management of 11 cancer centers in U. S. hospitals. Zeneca owns a 50 percent stake in these centers known collectively as Salick
Health Care.

The link between the ACS and NCI and Zeneca is especially strong when it comes to tamoxifen. The ACS and NCI continue aggressively to promote the tamoxifen trial, which is the cornerstone of its minimal prevention program. On March 7, 1997, the NCI Press Office released a four-page "For Response to Inquiries on Breast Cancer." The brief section on prevention reads:

" Researchers are looking for a way to prevent breast cancer in women at high risk. ... Alargestudy [is underway] to see if the drug tamoxifen will reduce cancer risk in women age 60 or older and in women 35 to 59 who have a pattern of risk factors for breast cancer. This study is also a model for future studies of cancer prevention. Studies of diet and nutrition could also lead to preventive strategies."

Since Zeneca influences every leaflet, poster, publication, and commercial produced by National Breast Cancer Awareness Month, it is no wonder these publications make no mention of carcinogenic industrial chemicals and their relation to breast cancer. Imperial Chemical Industries, Zeneca's parent company, profits by manufacturing breast cancer- causing chemicals. Zeneca profits from treatment of breast cancer, and hopes to profit still more from the prospects of large-scale national use of tamoxifen for breast cancer prevention. National Breast Cancer Awareness Month is a masterful public relations coup for Zeneca, providing the company with valuable, if ill-placed, good will from millions of American women.

The Pesticide Industry
Just how inbred the relations between the ACS and the chemical industry are became clear in the spring of 1993 to Marty Koughan, a public television producer. Koughan was about to broadcast a documentary on the dangers of pesticides to children for the Public Broadcasting Service's hour-long show, Frontline. Koughan's investigation relied heavily on an embargoed, ground-breaking report
issued by the National Academy of Sciences in June of 1993 entitled "Pesticides in the Diet of Children." This report declared the nation's food supply "inadequately protected" from cancer-causing pesticides and a significant threat to the health of children.

An earlier report, issued by the Natural Resources Defense Council in 1989," Intolerable Risk: Pesticides in our Children's Food," had also given pesticide manufacturers failing marks. The report was released in high profile testimony to Congress by movie actress Meryl Streep. A mother of young children, Streep explained to a packed House chamber the report's findings, namely, that children were most at risk from cancer-causing pesticides on our food because they consume
a disproportionate amount of fruits, fruit juices, and vegetables relative to their size, and because their bodies are still forming. Shortly before Koughan's program was due to air, a draft of the script was mysteriously leaked to Porter- Novelli, a powerful public relations firm for produce growers and the agrichemical industry. In true Washington fashion, Porter-Novelli plays both sides of the fence, representing both government agencies and the industries they regulate. Its client list in 1993 included Ciba-Geigy, DuPont, Monsanto, Burroughs
Wellcome, American Petroleum Institute, Bristol-Meyers-Squibb,
Hoffman-LaRoche, Hoechst Celanese, Hoechst Roussel Pharmaceutical, Janssen Pharmaceutical, Johnson & Johnson, the Center for Produce Quality, as well as the U. S. Department of Agriculture, the NCI, plus other National Institutes of Health.

Porter-Novelli first crafted a rebuttal to help the manufacturers quell public fears about pesticide-contaminated food. Next, Porter-Novelli called up another client, the American Cancer Society, for whom Porter-Novelli had done pro bono work for years. The rebuttal that Porter-Novelli had just sent off to its industry clients was faxed to ACS Atlanta headquarters. It was then circulated by e-mail on March 22, 1993, internally- virtually verbatim from the memo Porter-Novelli
had crafted for a backgrounder for 3,000 regional ACS offices to have in hand to help field calls from the public after the show aired.

" The program makes unfounded suggestions . . . that pesticide residue in food may be at hazardous levels," the ACS memo read. "Its use of `cancer cluster' leukemia case reports and non-specific community illnesses as alleged evidence of pesticide effects in people is unfortunate. We know of no community cancer clusters
which have been shown to be anything other than chance grouping of cases and none in which pesticide use was confirmed as the cause."
This bold, unabashed defense of the pesticide industry, crafted by Porter- Novelli, was then rehashed a third time, this time by the right-wing group, Accuracy in Media (AIM). AIM's newsletter gleefully published quotes from the ACS memo in an article with the banner headline: "Junk Science on PBS." The article opened with "Can we afford the Public Broadcasting Service?" and went on to disparage Koughan's documentary on pesticides and children. "In Our
Children's Food . . . exemplified what the media have done to produce these `popular panics' and the enormously costly waste [at PBS] cited by the New York Times."

When Koughan saw the AIM article he was initially outraged that the ACS was being used to defend the pesticide industry. "At first, I assumed complete ignorance on the part of the ACS," said Koughan. But after repeatedly trying, without success, to get the national office to rebut the AIM article, Koughan began to see what was really going on. "When I realized Porter-Novelli represented five agrichemical companies, and that the ACS had been a client for years,
it became obvious that the ACS had not been fooled at all," said Koughan. "They were willing partners in the deception, and were in fact doing a favor for a friend- by flakking for the agrichemical industry."
Charles Benbrook, former director of the National Academy of Sciences Board of Agriculture, worked on the pesticide report by the Academy of Sciences that the PBS special would preview. He charged that the role of the ACS as a source of information for the media representing the pesticide and produce industry was "unconscionable" (11). Investigative reporter Sheila Kaplan, in a 1993
Legal Times article, went further: "What they did was clearly and unequivocally over the line, and constitutes a major conflict of interest" (12).

Cancer Drug Industry
The intimate association between the ACS and the cancer drug industry, with cur-rent annual sales of about $12 billion, is further illustrated by the unbridled aggression which the Society has directed at potential competitors of the industry (13). Just as Senator Joseph McCarthy had his "black list" of suspected communists and Richard Nixon his environmental activist "enemies list," so too the ACS
maintains a "Committee on Unproven Methods of Cancer Management" which periodically "reviews" unorthodox or alternative therapies. This Committee is comprised of "volunteer health care professionals," carefully selected proponents of orthodox, expensive, and usually toxic drugs patented by major pharmaceutical companies, and opponents of alternative or "unproven" therapies which are
generally cheap, nonpatentable, and minimally toxic (13).

Periodically, the Committee updates its statements on "unproven methods," which are then widely disseminated to clinicians, cheerleader science writers, and the public. Once a clinician or oncologist becomes associated with "unproven methods," he or she is blackballed by the cancer establishment. Funding for the
accused "quack" becomes inaccessible, followed by systematic harassment. The highly biased ACS witch-hunts against alternative practitioners is in striking contrast to its extravagant and uncritical endorsement of conventional toxic chemotherapy. This in spite of the absence of any objective evidence of improved survival rates or reduced mortality following chemotherapy for all but some relatively
rare cancers.

In response to pressure from People Against Cancer, a grassroots group of cancer patients disillusioned with conventional cancer therapy, in 1986 some 40 members of Congress requested the Office of Technology Assessment (OTA), a Congressional think tank, to evaluate available information on alternative innovative therapies. While initially resistant, OTA eventually published a September 1990 report that identified some 200 promising studies on alternative
therapies. OTA concluded that the NCI had "a mandated responsibility to pursue this information and facilitate examination of widely used `unconventional cancer treatments' for therapeutic potential" (14).

Yet the ACS and NCI remain resistant, if not frankly hostile, to OTA's recommendations. In the January 1991 issue of its Cancer Journal for Clinicians ACS referred to the Hoxsey therapy, a nontoxic combination of herb extracts developed in the 1940s by populist Harry Hoxsey, as a "worthless tonic for cancer." However, a detailed critique of Hoxsey's treatment by Dr. Patricia Spain Ward, a leading contributor to the OTA report, concluded just the opposite:" More recent literature leaves no doubt that Hoxsey's formula does indeed contain many plant substances of marked therapeutic activity" (13).

Nor is this the first time that the Society's claims of quackery have been called into question or discredited. A growing number of other innovative therapies originally attacked by the ACS have recently found less disfavor and even acceptance. These include hyperthermia, tumor necrosis factor (originally called Coley's toxin), hydrazine sulfate, and Burzynski's antineoplastons. Well over 100 promising alternative nonpatented and nontoxic therapies have already been identified (15). Clearly, such treatments merit clinical testing and evaluation by
the NCI using similar statistical techniques and criteria as established for conventional chemotherapy. However, while the FDA has approved approximately 40 patented drugs for cancer treatment, it has still not approved a single nonpatented alternative drug.

Subsequent events have further isolated the ACS in its fixation on orthodox treatments. Bypassing the ACS and NCI, the National Institutes of Health in June 1992 opened a new Office of Alternative Medicine for the investigation of unconventional treatment of cancer and other diseases. Leading proponents of conventional therapy were invited to participate. The ACS refused and still refuses. The NCI grudgingly and nominally participates while actively attacking
alternative therapy with its widely circulated Cancer Information Services. Meanwhile, the NCI's police partner, the FDA, uses its enforcement authority against distributors and practitioners of innovative and nontoxic therapies. In an interesting recent development, the Center for Mind-Body Medicine in Washington, D. C., held a two-day conference on Comprehensive Cancer Care: Integrating Complementary and Alternative Medicine. According to Dr. James Gordon, president of the Center and chair of the Program Advisory Council of the NIH Office of Alternative Medicine, the object of the conference was to bring together practitioners of mainstream and alternative medicine, together with cancer patients and high-ranking officials of the ACS and NCI. Dr. Gordon warned alternative practitioners that "they're going to need to get more rigorous
with their work- to be accepted by the mainstream community" (16). However, no such warning was directed at the highly questionable claims by the NCI and ACS for the efficacy of conventional cancer chemotherapy. As significantly, criticism of the establishment's minimalistic priority for cancer prevention was effectively discouraged.

THE ROLE OF ACS IN THE WAR AGAINST CANCER
The launching of the 1971 War Against Cancer provided the ACS with a well-exploited opportunity to pursue it own myopic and self-interested agenda. Its strategies remain based on two myths- that there has been dramatic progress in the treatment and cure of cancer, and that any increase in the incidence and mortality of cancer is due to aging of the population and smoking, while denying any significant role for involuntary exposures to industrial carcinogens in air, water, consumer products, and the workplace.

As the world's largest nonreligious "charity," with powerful allies in the private and public sectors, ACS policies and priorities remain unchanged. Despite periodic protests, threats of boycotts, and questions on its finances, the Society leadership responds with powerful public relations campaigns reflecting denial and manipulated information and pillorying its opponents with scientific McCarthyism

FloridaLady

May be baking sode is the the cure....but I going to have to do Phase I trails again.  We've already been told there is NO proof any of these new drugs will work. It all starts some place.

Again please research CHEMO it does not KILL CANCER! May be able to control growth for a short period of time but can not make you stay in remission with breast cancer.  How many billions have been spent on chemo and it does not CURE cancer either? This is my problem with research. 

Flalady

Anonymous

Fla"Lady" you do realize, don't you, that when you post pages of material that is not your own, that you should cite the source. Otherwise it is plagiarism, a violation of the author's copyright, and possibly a violation of the TOS of this site.

Byron

Look again, LJ13, I believe you will find four (4) links that show where FloridaLady got her materials.

Byron

Anonymous

Ah splendid. This web site lists mammograms, hot dogs, milk, talcum powder, hair dye as causes of cancer (among other non-proven causes).

It proceeds to trash the National Cancer Institute and the ACS, as well as the "medical industrial complex." Hmmm, where have I heard that terminology before? Why, right here, in this forum.

This is not a reputable source.

Byron

"LJ13 wrote:

"Ah splendid. This web site lists mammograms, hot dogs, milk, talcum powder, hair dye as causes of cancer (among other non-proven causes).

"It proceeds to trash the National Cancer Institute and the ACS, as well as the "medical industrial complex." Hmmm, where have I heard that terminology before? Why, right here, in this forum.

"This is not a reputable source."

And your sources are reputable?

You accused her (FloridaLady) of stealing ("...plagiarism, a violation of the author's copyright, and possibly a violation of the TOS of this site").  Isn't an apology from you in order?

Byron

Anonymous

Byron, having hyperlinks within a web page is not citation of source. No apology is called for. She has presented material that is not quoted and the source is not attributed. That is exactly what I described.

Byron

LJ13, her defense against your charge is contained (and obvious) within her post.

Byron

Husband11

Byron quotes Timothy:

 "Its hard to believe that the good Doctor Simoncini is so compelled by the evidence he's found as to the cause and cure of cancer, that he could not share such compelling evidence with his colleagues. Its also difficult to understand that a man that wants to help people, wouldn't take the time to ensure that his 'cure' reaches mainstream acceptance and help the whole world, not just the people he has time to treat. There may be explanations why this is, but I can't think of any good one. Can you imagine the Doctor that discovered insulin or penicillin, saying, 'Oh, screw it, I'm not going to take the time to present my work to my colleagues and have this understood and accepted, I'll just languish in ridicule and keep it to myself, treat a handful of patients in hidden locations, away from the hands of authority.' "

Where, Tomothy, did you find this information?

 I went to his website and I can find no presentation of credible evidence.  He doesn't have any laboratory analysis of biopsy diagnosing the fungal infection.  He, quite laughably, concludes its fungal because it is white.  So if he doesn't know anything solid, and not wildly speculative, what has he got to tell his colleages to convince them?  What does he have himself to go on, when he can't even present it to the world?  Why would he keep the good evidence secret?  Surely the evidence that led him to conclude cancer is a fungal infection could be shared with other knowledgeable medical researchers who would agree with him.  It should be pretty easy to prove the tumor removed contained fungus, or to do pathology on the deceased's metastacized cancer to show it was also fungal.  It should be a piece of cake to prove what he asserts.  So where is the proof that cancer is fungal?  He can't find a single ally in the medical field that agrees?  Where are they? Why aren't there any?  Its not like science isn't receptive of new ideas.  It thrives on new ideas, its just that they need evidence to back them up or else what are they?  I studied microbiology and botony at university, its not that difficult to positively identify a fungus.  Where is the laboratory report showing the metastasis containing fungus as he purports?  Without this evidence, that should be easy to obtain, is there any doubt as to why thinking people are skeptical of his claims?

 I'm not saying he's wrong, I'm just saying there is a certain burden of proof on such a claim, and I'm not hearing about any reasonable attempt to fulfil it.

Byron

Timothy,

Read your post again, you should be able to see your contradictions.

Byron

PS: I'm not saying that he (Simoncini) is correct, just that there is no science so far to prove him wrong.